SC
BOLT icon

Shay Capital’s Bolt Biotherapeutics BOLT Stock Holding History

Shay Capital’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.2K Sell
14,905
-367
-2% -$1.91K 0.01% 453
2025
Q4 		$83.5K Sell
15,272
-686
-4% -$3.68K 0.01% 453
2025
Q3 		$84.9K Buy
+15,958
New +$88.5K 0.01% 387

Other funds holding BOLT

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shay Capital's BOLT Position: Q1 2026 in Review

Shay Capital reduced its Bolt Biotherapeutics (BOLT) stake by 2.4% in Q1 2026, selling an estimated $1.91K and leaving 14,905 shares worth $60.2K. The position accounts for 0.01% of the portfolio, ranked #453.

Shay Capital first reported a position in BOLT in Q3 2025 and has held it in 3 quarters since. The position peaked at $84.9K in Q3 2025. 24 funds tracked by Wall St. Rank hold BOLT as of Q1 2026.

  • Shay Capital held 14,905 shares of Bolt Biotherapeutics worth $60.2K as of Q1 2026.
  • Shay Capital sold 367 Bolt Biotherapeutics shares in Q1 2026, an estimated $1.91K.
  • Bolt Biotherapeutics made up 0.01% of Shay Capital's portfolio in Q1 2026, its #453 holding.
  • Shay Capital first reported a position in Bolt Biotherapeutics in Q3 2025 and has held it in 3 quarters since.
  • Shay Capital's Bolt Biotherapeutics position peaked at $84.9K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.